Question 1

What are the expected benefits of continuing with teduglutide?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 clinical trial (NCT01560403). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 clinical trial (NCT01560403). Contact the study team or your healthcare provider for specific answers.

Question 3

How will this treatment fit into my overall care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 clinical trial (NCT01560403). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will be involved during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 clinical trial (NCT01560403). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 clinical trial (NCT01560403). Contact the study team or your healthcare provider for specific answers.

What this study is about